"Across our three businesses, we are driving good demand for our broad product portfolio and recent product launches," Chief Executive Officer Siggi Olafsson said.
Hikma backs annual outlook boosted by medicine demand
More from Industry NewsMore posts in Industry News »
- Sanofi and Translate Bio start clinical trial for mRNA flu vaccine
- Dr Reddy’s Laboratories launches Icosapent Ethyl Capsules in US
- Bharat Biotech’s Covaxin gets SEC approval on its Phase 3 trials efficacy data
- Covid-19 has highlighted the Indian pharma industry’s potential in transforming into an innovation hub: Sudarshan Jain